WallStreetZenWallStreetZen

NASDAQ: TTRX
Turn Therapeutics Inc Stock Ownership - Who owns Turn Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Turn Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Zuraiz ChaudharyOfficer2025-12-122,500$3.50
$8.75kBuy
Arthur F. GoldenDirector2025-11-249,868$3.44
$33.95kBuy
Zuraiz ChaudharyOfficer2025-11-211,000$3.29
$3.29kBuy
Arthur F. GoldenDirector2025-11-2120,532$2.87
$58.93kBuy
Zuraiz ChaudharyOfficer2025-11-201,450$2.61
$3.78kBuy
Zuraiz ChaudharyOfficer2025-11-172,500$3.62
$9.05kBuy
Abraham ChesedInsider2025-10-2314,286$4.60
$65.72kBuy
Arthur F. GoldenDirector2025-10-2320,202$4.95
$100.00kBuy
Zuraiz ChaudharyOfficer2025-10-235,050$4.95
$25.00kBuy

1 of 1

TTRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TTRX insiders and whales buy or sell their stock.

TTRX Shareholders

What type of owners hold Turn Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bradley Evan Burnam51.75%15,416,260$149.08MInsider
Abraham Chesed4.86%1,447,268$14.00MInsider
Arthur F. Golden1.21%360,602$3.49MInsider
Martin William Dewhurst0.07%21,882$211.60kInsider
Zuraiz Chaudhary0.04%12,500$120.88kInsider
Neilesh Shailesh Ghodadra0.03%10,000$96.70kInsider
Andrew Gengos0.03%10,000$96.70kInsider
Kent Edward Kester0.03%10,000$96.70kInsider
Steelpeak Wealth LLC0.00%249$2.41kInstitution
Steelp0.00%249$2.41kInstitution

1 of 3

TTRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TTRX0.00%58.04%Net Buying
ACIU0.02%4.41%Net Selling
PYXS0.04%40.13%Net BuyingNet Buying
BCYC0.05%43.51%Net SellingNet Selling
SION0.11%49.99%Net SellingNet Selling
View Top Biotech Stocks

Turn Therapeutics Stock Ownership FAQ

Who owns Turn Therapeutics?

Turn Therapeutics (NASDAQ: TTRX) is owned by 0.00% institutional shareholders, 58.04% Turn Therapeutics insiders, and 41.96% retail investors. Bradley Evan Burnam is the largest individual Turn Therapeutics shareholder, owning 15.42M shares representing 51.75% of the company. Bradley Evan Burnam's Turn Therapeutics shares are currently valued at $155.24M.

If you're new to stock investing, here's how to buy Turn Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.